Profil
Dr Colas studied molecular biology at the University of Lyon and At the end of 1993, he joined the laboratory of Roger Brent, at the Department of Molecular Biology of Massachusetts General Hospital (Harvard Medical School, Boston, USA), where he contributed to the development of the peptide aptamer technology.
Dr Colas was recruited by the INSERM and came back to Lyon in 1998 to join Dr Rudkin's lab.
He pursued his work on peptide aptamer technologies.
In 2002, Dr Colas took a leave from the INSERM to become Scientific Director of Aptanomics.
Tidigare kända positioner av Pierre Colas
| Företag | Position | Slut |
|---|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Teknisk/Vetenskaplig/F&U Direktör | 2008-01-24 |
Pierre Colass utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Health Technology |
Ecole Centrale Lyon
Ecole Centrale Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École Normale Supérieure de Lyon
École Normale Supérieure de Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















